Show an ad over header. AMP

COVID-19 shows a bright future for vaccines

Promising results from COVID-19 vaccine trials offer hope not just that the pandemic could be ended sooner than expected, but that medicine itself may have a powerful new weapon.

Why it matters: Vaccines are, in the words of one expert, "the single most life-saving innovation ever," but progress had slowed in recent years. New gene-based technology that sped the arrival of the COVID vaccine will boost the overall field, and could even extend to mass killers like cancer.


By the numbers: As the first COVID-19 vaccines near emergency authorization, it's worth reflecting on just how fast their development has been.

  • Vaccines usually take more than 10 years to go from discovery to regulatory approval, and the fastest on record was four years, for the mumps.
  • The world now has three vaccines — from Pfizer, Moderna and AstraZeneca — ready for regulatory approval just one year after what are believed to be the first confirmed cases of COVID-19 in China.

How it works: The COVID-19 vaccines progressed so swiftly because they were built using a new platform: gene-based technology that harnesses messenger RNA (mRNA) to essentially instruct the human body to make the vaccine itself.

  • Conventional vaccines use either a weakened virus or purified signature viral proteins to prompt the body to safely generate immunity. That's effective, but the act of growing the attenuated virus or purifying the proteins is slow and laborious.
  • mRNA vaccines, by contrast, can be developed almost as quickly as a virus can be genetically sequenced — Moderna shipped the first batch of its vaccine for clinical study a month and a half after Chinese authorities shared the genetic sequence of the novel coronavirus.

What they're saying: "It could be quite a new era for vaccines and vaccinology," Brendan Wren, a professor of vaccinology at the London School of Hygiene and Tropical Medicine, told USA Today. "We seemed to move ahead in this one year 10 years."

What's next: As mRNA technology improves, so should the speed at which new vaccines can be developed and rolled out, which would be hugely beneficial when the inevitable next pandemic hits.

Our thought bubble: The COVID-19 vaccine represents technological innovation at its best, in that it can save us from ourselves.

  • The ability to rapidly develop a vaccine for every new disease would relieve human beings of the need to make social distancing tradeoffs they can't seem to make.

Scientists are also hopeful that mRNA and other gene-based platforms could improve mediocre existing vaccines like the perennially underwhelming flu shot and give researchers a new approach for challenging viruses like HIV.

  • Pharma companies are even exploring whether the technology could yield treatments for heart disease and cancer, which between them kill more than 1.2 million Americans a year.

Yes, but: While both the effectiveness and the safety data of the COVID-19 vaccines have been sterling — albeit with some questions around AstraZeneca's candidate — mRNA vaccines have never been used before, and we won't know for sure how well they work until they go to work.

  • Distributing vaccines to just about everyone on the globe has also never been attempted before, and unfortunately there's no gene-based shortcut for the hard work of logistics.

The bottom line: The proof will be in the shots themselves, but right now it looks like finding a new and better way of making vaccines will be one of the few goods things to come out of our plague year.

The cloudy science on school reopening during the pandemic

President Biden's plan to accelerate the reopening of K-8 schools faces major challenges from a still out-of-control pandemic and more contagious coronavirus variants.

Why it matters: The longer American kids miss in-person schooling, the further they fall behind. But the uncertain state of the science on the role young children play in the pandemic continues to complicate efforts to reopen schools.

Keep reading... Show less

Focus group: Former Trump voters say he should never hold office again

"Relief" is the top emotion some swing voters who used to support Donald Trump say they felt as they watched President Biden's swearing-in, followed by "hope."

Why it matters: For voters on the bubble between parties, this moment is less about excitement for Biden or liberal politics than exhaustion and disgust with Trump and a craving for national healing. Most said Trump should be prohibited from ever holding office again.

Keep reading... Show less

Schumer: Trump impeachment trial to start week of Feb. 8

The Senate will begin former President Trump's impeachment trial the week of Feb. 8, Majority Leader Chuck Schumer announced Friday on the Senate floor.

Why it matters: Trump is the only president in U.S. history to be impeached twice for “incitement of insurrection" after a violent pro-Trump mob breached the U.S. Capitol, resulting in five deaths.

Keep reading... Show less

CDC shifts COVID vaccine guidance, expanding minimum interval between doses for exceptional cases

Patients can space out the two doses of the coronavirus vaccine by up to six weeks if it’s "not feasible" to follow the shorter recommended window, according to updated guidance from the Centers for Disease and Control and Prevention.

Driving the news: With the prospect of vaccine shortages and a low likelihood that supply will expand before April, the latest changes could provide a path to vaccinate more Americans — a top priority for President Biden.

Keep reading... Show less

Texas attorney general sues Biden administration over deportation freeze

Texas Attorney General Ken Paxton is suing the Biden administration in federal district court over its 100-day freeze on deporting unauthorized immigrants, and asking for a temporary restraining order.

Between the lines: The freeze went into effect Friday, temporarily halting most immigration enforcement in the U.S. In the lawsuit, Paxton claims the move "violates the U.S. Constitution, federal immigration and administrative law, and a contractual agreement between Texas" and the Department of Homeland Security.

Keep reading... Show less

Biden administration unveils 3-pronged plan to combat domestic extremism

White House press secretary Jen Psaki announced at a briefing on Friday that the Biden administration will roll out a three-pronged, interagency plan to assess and combat the thread by domestic violence extremism.

Why it matters: The federal government's approach to domestic extremism has come under scrutiny in the wake of the Jan. 6 attacks on the Capitol by a pro-Trump mob. In his inaugural address, Biden repudiated political extremism, white supremacy and domestic terrorism, vowing to defeat them.

Keep reading... Show less

Senate confirms retired Gen. Lloyd Austin as defense secretary

The Senate voted 93-2 on Friday to confirm retired Gen. Lloyd Austin as secretary of defense. Sens. Mike Lee (R-Utah) and Josh Hawley (R-Mo.) were the sole "no" votes.

Why it matters: Austin is the first Black American to lead the Pentagon and President Biden's second Cabinet nominee to be confirmed.

Keep reading... Show less

House will transmit article of impeachment to Senate on Monday, Schumer says

Senate Majority Leader Chuck Schumer (D-N.Y.) announced that the House will deliver the article of impeachment against former President Trump for "incitement of insurrection" on Monday.

Why it matters: The Senate is constitutionally required to begin the impeachment trial at 1 p.m. the day after the article is transmitted. Minority Leader Mitch McConnell (R-Ky.) had been pushing for the trial to begin in mid-February, arguing that it will force the Senate to delay other important business.

This story is breaking news. Please check back for updates.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories